Inside Innovation

Life Science Washington is helping founders strengthen investor messaging while promoting Seattle’s position as a leading hub for AI-driven biotechnology. Marc Cummings highlighted the growing

Sana Biotechnology reported that its donor-derived islet cell therapy continued producing insulin for 14 months in one patient with Type 1 diabetes, with no safety

Vertex reported phase 3 data showing povetacicept significantly reduced proteinuria compared to placebo in immunoglobulin A nephropathy and said it plans to seek FDA approval

To better serve a broader range of entrepreneurs and companies, LSW Institute is now LSW Entrepreneurship & Venture Services, offering a wider range of support

Seattle-based CounterX Therapeutics has secured exclusive licensing agreements with the University of Washington and the University of Minnesota to develop treatments aimed at preventing opioid

A team from the University of Washington won the 2026 Hollomon Health Innovation Challenge with CPRight, a device designed to provide real-time feedback that improves

Washington has a problem. We have too many good jobs. Why is that a problem? Not enough of them are going to Washingtonians. As leaders

Seattle’s life sciences ecosystem stands out for companies applying artificial intelligence to accelerate drug discovery, diagnostics and therapeutic development. Greater Seattle ranks among the top

A 15-year follow-up analysis led by researchers at Fred Hutch Cancer Center suggests that follicular lymphoma may be curable for some patients treated with chemoimmunotherapy.

Researchers from Weill Cornell Medicine and the Allen Institute have discovered that pain-sensing neurons in the gut help coordinate the immune system’s response to intestinal

Fred Hutch Cancer Center scientists have developed genetically human monoclonal antibodies that block Epstein-Barr virus from infecting human immune cells, marking a key milestone in

The Allen Institute has partnered with Anthropic to design and deploy custom autonomous AI agents that will accelerate bioscience research and help unlock new approaches